Disc Medicine Long Term Debt

Disc Medicine (IRON) currently reports a long-term debt of $1.2M as of June 2026. That compares with $30M in the prior-year period — down 96.0% year over year. Use the charts on this page to explore Disc Medicine's long-term debt history and peer comparisons.

Disc Medicine's long-term debt decreased from $30M to $1.2M — a 96.0% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Disc Medicine reported $1.2M in long-term debt as of June 2026. That compares with $30M in the prior-year period — down 96.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $1.2M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Disc Medicine, and consider following IRON for alerts when major investors trade the stock.

Disc Medicine is classified in the Healthcare sector. On long-term debt, it currently shows $1.2M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IRON with unrelated industries.